Application of low-dose etomidate combined with oxycodone and midazolam in endoscopic injection sclerotherapy
Int. Journal of Clinical Pharmacology and Therapeutics · 01.03.2023 · 61 (03) · 122-128
DOI: 10.5414/cp204341 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.03.2023. Verfasst von Jie Yao und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Etomidate, Propofol, Respiratory Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Yao, J., Hao, S., Zhou, C., Cao, Y., & Quan, Z. (2023). Application of low-dose etomidate combined with oxycodone and midazolam in endoscopic injection sclerotherapy. Int. Journal of Clinical Pharmacology and Therapeutics, 61(03), 122-128. https://doi.org/10.5414/cp204341
Vancouver
Yao J, Hao S, Zhou C, Cao Y, Quan Z. Application of low-dose etomidate combined with oxycodone and midazolam in endoscopic injection sclerotherapy. Int. Journal of Clinical Pharmacology and Therapeutics. 2023;61(03):122-128. doi:10.5414/cp204341
BibTeX
@article{Yao2023,
author = {Yao, Jie and Hao, Shuai and Zhou, Chen and Cao, YingHao and Quan, ZheFeng},
title = {Application of low-dose etomidate combined with oxycodone and midazolam in endoscopic injection sclerotherapy},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2023},
volume = {61},
number = {03},
pages = {122--128},
doi = {10.5414/cp204341}
}
EUVIMED